Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
February 2018—Thermo Fisher Scientific released its MagMax DNA Multi-Sample Ultra 2.0 reagents, which provide genetic testing companies, labs, and service providers with high-throughput DNA extraction from blood, saliva, buffy coat, and buccal swabs. The next-generation reagents can purify DNA from 96 samples in 45 minutes on Thermo Scientific KingFisher instruments using a simplified protocol for either small- or large-volume sample input.
February 2018—Spot Imaging introduced its CytoXpress, an FDA-approved consultation method that lets clinicians and technologists transmit a live, interactive image stream directly to the user’s computer, eliminating the travel and wait time associated with on-site consults.
February 2018—Vector Laboratories introduced the TrueView Autofluorescence Quenching Kit for removing unwanted fluorescence in formalin-fixed, paraffin-embedded tissue samples, blood cells, and structural elements such as collagen and elastin.
February 2018—Ortho Clinical Diagnostics and EKF Diagnostics announced an agreement that allows Ortho customers to access EKF’s Beta-Hydroxybutyrate LiquiColor Assay, a CLIA moderate-complexity test for use on Ortho’s Vitros 4600 Chemistry System and Vitros 5600 Integrated System.
February 2018—LGC Maine Standards announced the release of its Validate SP2 linearity and calibration verification kit. The Validate SP2 kit, in a human serum matrix, evaluates albumin, ceruloplasmin, C-reactive protein, haptoglobin, prealbumin, and rheumatoid factor. Each kit offers five distinct concentrations covering the reportable ranges of Roche Cobas analyzers.
February 2018—MedTest announced the commercial availability of four forensic use only urine drug tests for use on its BS-200, BS-480, and BA-800M chemistry analyzers. The four new assays are DRI Fentanyl, Cedia AB-PINACA (spice K2), Cedia UR-144/XLR-11 (spice K2), and DRI Ethyl Glucuronide.
February 2018—Approximately 250 professionals attended an inspector training program organized by National Reference Laboratory, part of Mubadala’s network of health care providers, and the College of American Pathologists. Faculty included members of the CAP leadership as well as worldwide and local experts experienced with the quality accreditation process.
February 2018—Oasis Diagnostics has launched a testing service, through its Oasis Research Laboratory, for salivary hormone biomarker assessment using discreet panels. The service aims to relieve some of the complexity inherent in testing for biomarkers in the research setting.
February 2018—Sekisui Diagnostics and Mesa Biotech announced a strategic alliance to distribute the Mesa Biotech POC molecular system for Flu A/Flu B. Sekisui Diagnostics will assume exclusive distribution of the Mesa Biotech POC system in the United States and Canada, pending FDA clearance.
February 2018—Illumina introduced its NextSeq 550Dx instrument, the company’s second FDA-regulated and CE-IVD-marked next-generation-sequencing system. Illumina also announced that the intended use for the MiSeqDx instrument now includes the use of DNA libraries generated from formalin-fixed, paraffin-embedded tissues.
